fashion -WSS

fashion

author：fashion 2025-09-29 22:50:43 - browse：54725

A collage illustration with a patient in the center with a hand to the left administering treatment and a doctor in the background. -- health tech coverage from STAT — Katy Lemay for STAT

The makers of minimally invasive surgical devices seemed poised to capture a wide swath of the obesity treatment market. Patients needed an option that lay between the two treatment extremes: cutting open the abdomen to perform permanent bariatric surgery, or changing your diet or exercise routine.

Then, a new class of weight loss medications that successfully mimic the feeling of fullness hit the market, and the landscape changed.

“It turns out that what came along — before those endoscopic devices have really matured — is these new drugs,” said Lee Kaplan, director of Massachusetts General’s obesity institute. Since the Food and Drug Administration approved Novo Nordisk’s Wegovy in 2021, it and similar drugs that followed have swiftly captured the public’s interest — and are on their way to generating billions of dollars in sales.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： What to know about the judge who will handle the Trump case

WSS

After a decade, new Gardasil ad campaign gets it (mostly) right

Scientists grapple with ethics of stem cell research

Indictment alleges Trump's ex

After a decade, new Gardasil ad campaign gets it (mostly) right

A new ‘biological computer' targets cancer while sparing healthy cells

Caribou posts encouraging results on off

hotspot

fashion

leisure time

Novavax promises a turnaround & Lilly roils the obesity market

Stanford president’s abrupt resignation sparks debate

In Memoriam: Notable people who died in 2023

Patients, digital health players weigh in on FTC's data privacy plan

Sports medicine is finally prioritizing gender equality

US jobless claims fall again as labor market continues to flash strength

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Biogen’s boardroom scandal saddles CEO with first crisis

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Illumina slashes 2023 revenue projections yet again

focus

Jan. 6 charges against Trump would add to his mounting legal peril as he campaigns for 2024

Novo Nordisk touts Wegovy study, but still struggling with supply

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

5 dead in mass shooting on Caribbean island of St. Vincent: Police

'CMA Fest' 2023: How to watch, who is performing and more

Delta passengers in Vegas fall sick while waiting on flight in triple

focus

leisure time

hotspot

leisure time